SEEIIST Association, Rue de Battoirs 7, c/o PKF Fiduciaire SA, 1205 Geneva Switzerland
Author: seeiist
Time to Act: The CERN Yellow Report Highlights the Urgent Need for Heavy Ion Therapy in South East Europe
SEEIIST is proud to have contributed to the newly published CERN Yellow Report, “Heavy Ion Therapy in Europe: Present and Future”. This comprehensive document provides a strategic vision for the development of heavy ion therapy across Europe, reinforcing the importance of expanding access to cutting-edge cancer treatment—an opportunity that South Read More…
SEEIIST 3-D DESIGN
Video clip is based on the 3-D design of SEEIIST, which was sponsored by the Ministry of Montenegro together with CERN
Forging Frontiers in Science: SEEIIST’s Role at the I.FAST Annual Meeting
In a significant display of scientific collaboration and progress, SEEIIST’s own Luca Garolfi presented at the I.FAST annual meeting, marking a momentous occasion for our institute. The presentation emphasized our ongoing projects and the strides we are making in the field of sustainable technologies. Garolfi’s speech touched upon the institute’s Read More…
Particle Therapy MasterClasses 2024
The Particle Therapy MasterClass (PTMC), that was introduced in 2020, is a hands-on educational activity, addressing high-school students, which demonstrates direct applications of fundamental sciences, in particular physics, for the benefit of society, focusing on the treatment of cancer tumours with charged particles. The PTMC is integrated in the International Read More…
Call for Applications: Challenged Based Innovation Program
An Opportunity for a SEEIIST Student Sponsored by HITRIplus We are excited to announce a unique opportunity for a student from SEEIIST member states, supported by HITRIplus. Join us in the journey of innovation and discovery through the Challenged Based Innovation Program. Program Overview The Challenged Based Innovation Program is Read More…
12th Seminar of HITRIplus – New trends and initiatives in accelerators for ion therapy of cancer, Maurizio Vretenar, CERN
📢We are excited to announce that the 12th HITRIplus seminar is coming up, and we have a very special guest speaker joining us. Maurizio Vretenar, from CERN, will be presenting on an intriguing topic that you won’t want to miss! 👀 “New trends and initiatives in accelerators for ion therapy of cancer” Read More…
HITRIplus seminar – 20.04.2023 17pm – LIGHT: a linear accelerator for cancer therapy, AVO-ADAM
The next exciting HITRIplus https://www.hitriplus.eu/ seminar will take place on Thursday, April 20, 2023, from 17.00 CET. Alberto Degiovanni, Anna Maria Kolano and Stephen Myers will present LIGHT: a linear accelerator for cancer therapy (Advanced Oncotherapy, https://www.avoplc.com/en-gb/ ). We would be delighted to have your participation. Please forward and share this information with those who might be interested in attending the seminar. Read More…
SPECIALISED COURSE ON CLINICAL ASPECTS OF HEAVY ION CANCER THERAPY RESEARCH
We are pleased to announce a one-week online international specialised course on Clinical Aspects of Heavy Ion Cancer Therapy Research which will be held from the 3rd to the 7th of July 2023, online on Zoom; see https://indico.cern.ch/event/1248018/ It is free of charge and is funded by the European Union’s H2020 research and innovation programme through the HITRIplus project https://www.hitriplus.eu/. This Read More…
STRONG POLITICAL SUPPORT FOR THE PROJECT REALIZATION
BERN, SWITZERLAND, September 13-15. The high-level event A Science Diplomacy Roadmap for South East Europe – The Example of SEEIIST was organized by the SEEIIST Steering Committee and Swiss Federal Department for Foreign Affairs (FDFA). The aim of the conference was to summarise the status of the SEEIIST project initiative and Read More…
Acknowledgement
This project has received funding from the European Union’s Horizon 2020 Research and Innovation programme under Service Facility in Support of the Strategic Development of International Cooperation in Research and Innovation
No 30-CE-0838742/00-87.